Literature DB >> 15060071

Probing the role of crystallographically defined/predicted hinge-bending regions in the substrate-induced global conformational transition and catalytic activation of human phenylalanine hydroxylase by single-site mutagenesis.

Anne Jorunn Stokka1, Raquel Negrão Carvalho, João Filipe Barroso, Torgeir Flatmark.   

Abstract

Phenylalanine hydroxylase (PAH) is generally considered to undergo a large and reversible conformational transition upon l-Phe binding, which is closely linked to the substrate-induced catalytic activation of this hysteretic enzyme. Recently, several crystallographically solvent-exposed hinge-bending regions including residues 31-34, 111-117, 218-226, and 425-429 have been defined/predicted to be involved in the intra-protomer propagation of the substrate-triggered molecular motions generated at the active site. On this basis, single-site mutagenesis of key residues in these regions of the human PAH tetramer was performed in the present study, and their functional impact was measured by steady-state kinetics and the global conformational transition as assessed by surface plasmon resonance and intrinsic tryptophan fluorescence spectroscopy. A strong correlation (r(2) = 0.93-0.96) was observed between the l-Phe-induced global conformational transition and V(max) values for wild-type human PAH and the mutant forms K113P, N223D, N426D, and N32D, in contrast to the substitution T427P, which resulted in a tetrameric form with no kinetic cooperativity. Furthermore, the flexible intra-domain linker region (residues 31-34) seems to be involved in a more local conformational change, and the biochemical/biophysical properties of the G33A/G33V mutant forms support a key function of this residue in the positioning of the autoregulatory sequence (residues 1-30) and thus in the regulation of the solvent and substrate access to the active site. The mutant forms revealed a variably reduced global conformational stability compared with wild-type human PAH, as measured by thermal denaturation and limited proteolysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060071     DOI: 10.1074/jbc.M400879200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

Review 2.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

3.  Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.

Authors:  Heidi Erlandsen; Angel L Pey; Alejandra Gámez; Belén Pérez; Lourdes R Desviat; Cristina Aguado; Richard Koch; Sankar Surendran; Stephen Tyring; Reuben Matalon; Charles R Scriver; Magdalena Ugarte; Aurora Martínez; Raymond C Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

4.  Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactor.

Authors:  Søren W Gersting; Michael Staudigl; Marietta S Truger; Dunja D Messing; Marta K Danecka; Christian P Sommerhoff; Kristina F Kemter; Ania C Muntau
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability.

Authors:  Søren W Gersting; Kristina F Kemter; Michael Staudigl; Dunja D Messing; Marta K Danecka; Florian B Lagler; Christian P Sommerhoff; Adelbert A Roscher; Ania C Muntau
Journal:  Am J Hum Genet       Date:  2008-06-05       Impact factor: 11.025

6.  Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering.

Authors:  Steve P Meisburger; Alexander B Taylor; Crystal A Khan; Shengnan Zhang; Paul F Fitzpatrick; Nozomi Ando
Journal:  J Am Chem Soc       Date:  2016-05-12       Impact factor: 15.419

7.  Modulation of Human Phenylalanine Hydroxylase by 3-Hydroxyquinolin-2(1H)-One Derivatives.

Authors:  Raquel R Lopes; Catarina S Tomé; Roberto Russo; Roberta Paterna; João Leandro; Nuno R Candeias; Lídia M D Gonçalves; Miguel Teixeira; Pedro M F Sousa; Rita C Guedes; João B Vicente; Pedro M P Gois; Paula Leandro
Journal:  Biomolecules       Date:  2021-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.